Undifferentiated embryonal sarcoma of the liver (UESL) is a rare aggressive mesenchymal pediatric tumor. Previously, reported outcomes have been very poor. Here, we report a single-center experience of five patients with UESL treated with upfront gross total resection and adjuvant chemotherapy. We have a median follow-up of 8 years with a range from 5 to 19 years with 100% event-free survival.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073002 | PMC |
| http://dx.doi.org/10.1002/pbc.26154 | DOI Listing |
Publication Analysis
Top Keywords
single-center experience
8
undifferentiated embryonal
8
embryonal sarcoma
8
sarcoma liver
8
experience undifferentiated
4
liver undifferentiated
4
liver uesl
4
uesl rare
4
rare aggressive
4
aggressive mesenchymal
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!